Clinical Trials on Muscle Invasive Bladder Cancer in China
Total 179 results
-
RenJi HospitalBeiGene; RemeGen Co., Ltd.RecruitingHER2 | Non-Muscle Invasive Bladder CancerChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
Binhui Biopharmaceutical Co., Ltd.RecruitingNon-muscle-invasive Bladder CancerChina
-
Huazhong University of Science and TechnologyRecruitingBladder Cancer | Non-Muscle-Invasive Bladder CancerChina
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
Chengdu CoenBiotech Co., LtdSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
RemeGen Co., Ltd.Not yet recruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.RecruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)China
-
Tianjin Medical University Second HospitalCSPC Pharmaceutical Group LimitedUnknownMuscle Invasive Bladder CancerChina
-
Jiangsu Yahong Meditech Co., Ltd aka AsierisRecruiting
-
Ruijin HospitalNot yet recruitingNon-muscle-invasive Bladder CancerChina
-
Qilu Pharmaceutical Co., Ltd.RecruitingNon-Muscle Invasive Bladder CancerChina
-
Jiangsu Yahong Meditech Co., Ltd aka AsierisActive, not recruiting
-
Jiangsu Yahong Meditech Co., Ltd aka AsierisRecruitingMuscle Invasive Bladder CancerUnited States, China
-
West China HospitalRemeGen Co., Ltd.Not yet recruitingNon-muscle Invasive Bladder CancerChina
-
Tianjin Medical University Second HospitalRecruitingMuscle Invasive Bladder Cancer Urothelial CarcinomaChina
-
Ruijin HospitalNot yet recruitingMuscle-Invasive Bladder CarcinomaChina
-
CG Oncology, Inc.RecruitingNon Muscle Invasive Bladder Cancer | High-grade Ta/ T1 Papillary Disease Bladder CancerUnited States, Korea, Republic of, Taiwan, Japan, Australia
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingNon-muscle-invasive Bladder CancerChina
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Colombia, ... and more
-
Tianjin Medical University Second HospitalActive, not recruitingUrothelial Carcinoma | Muscle Invasive Bladder CancerChina
-
Qilu Hospital of Shandong UniversityRecruiting
-
National Cancer Institute (NCI)RecruitingBladder Urothelial Carcinoma In Situ | Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Invasive Bladder Mixed CarcinomaUnited States, Guam, Puerto Rico
-
Zhujiang HospitalRecruitingBladder Cancer | Muscle-Invasive Bladder CarcinomaChina
-
Ferring PharmaceuticalsRecruiting
-
The First Affiliated Hospital with Nanjing Medical...RecruitingArtificial Intelligence | Muscle-invasive Bladder CancerChina
-
Chinese PLA General HospitalBeijing GeneX Health Technology Co., LtdRecruitingMuscle-Invasive Bladder CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...Peking University First Hospital; China-Japan Friendship HospitalRecruitingMuscle-invasive Bladder Cancer | Upper Tract Urinary CarcinomaChina
-
RenJi HospitalRecruitingRadiotherapy | Muscle Invasive Bladder Cancer | PD-1 | HER2 Expression | Antibody-drug ConjugatesChina
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder NeoplasmsKorea, Republic of, United States, United Kingdom, China, Japan, Brazil, Argentina
-
Janssen Research & Development, LLCRecruitingBladder CancerUnited States, Belgium, Korea, Republic of, Italy, Taiwan, China, United Kingdom, Germany, France, Argentina, Brazil, Poland, Spain, Czechia, Japan, Netherlands, India, Canada, Mexico, Australia, Portugal
-
PfizerActive, not recruitingNon-muscle Invasive Bladder CancerChina, United States, Spain, Belgium, Korea, Republic of, Australia, United Kingdom, Japan, France, Germany, Canada, Russian Federation, Poland, Italy
-
Fujian Medical University Union HospitalRecruitingUrinary Bladder Neoplasms | Treatment Outcome | Neoplasm Recurrence, Local | Multicenter Study | Immunotherapy, Active | BCG VaccineChina
-
Peking UniversityWithdrawnInvasive Bladder Cancer Stage IVChina
-
Janssen Research & Development, LLCActive, not recruitingUrinary Bladder NeoplasmsUnited States, Japan, China, Korea, Republic of, France, Belgium, Czechia, Taiwan, Italy, Poland, United Kingdom, Spain, Germany, Australia, Brazil, Argentina, India
-
Merck Sharp & Dohme LLCSeagen Inc.; Astellas Pharma Global Development, Inc.Active, not recruitingUrinary Bladder Cancer, Muscle-invasiveCanada, United States, Australia, Belgium, France, Hungary, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Thailand, Ukraine, Argentina, Colombia, Denmark, Germany, Ireland, Israel, Japan, Malaysia, Philippines, Sing... and more
-
Cancer Institute and Hospital, Chinese Academy...Shanxi Province Cancer HospitalRecruitingMuscle Invasive Bladder CarcinomaChina
-
RemeGen Co., Ltd.RecruitingMuscle Invasive Bladder CarcinomaChina
-
Sun Yat-sen UniversityRecruitingMuscle-Invasive Bladder Carcinoma | Radiotherapy | Programmed Cell Death Protein 1 InhibitorChina
-
Tianjin Medical University Second HospitalRecruitingHigh-Risk Non-Muscle Invasive Bladder Urothelial CarcinomaChina
-
Tianjin Medical University Second HospitalRecruitingNon-Muscle Invasive Bladder Urothelial Carcinoma | High-RiskChina
-
Tianjin Medical University Second HospitalRecruitingHer2 Overexpressing High-Risk Non-Muscle Invasive Bladder Urothelial CarcinomaChina
-
Bristol-Myers SquibbNektar TherapeuticsCompletedBladder Cancer | Bladder Tumor | Muscle-Invasive Bladder CancerRussian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
-
Hoffmann-La RocheRecruitingMuscle-invasive Bladder CancerBelgium, Korea, Republic of, Japan, Brazil, China, United States, Singapore, France, United Kingdom, Canada, Greece, Italy, Spain, Turkey, Russian Federation, Ukraine, Israel, Czechia, Colombia, Hong Kong, Argentina, Germany, Ireland, Polan... and more
-
Chengdu CoenBiotech Co., LtdHunan Cancer HospitalCompleted
-
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Recruiting
-
Henan Cancer HospitalRecruitingIntraoperative Complications | Perfusion; Complications | High-Risk, Non-Muscle Invasive Bladder Urothelial CarcinomaChina
-
Peking University First HospitalRecruitingUrinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder Tumors | Neoplasms, BladderChina
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
Zhujiang HospitalRecruiting